National Institutes of Health
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing January 25, 2027.
Jan 25, 2027
(178d left)Overview
The goal of this RFA is to continue to support canine cancer immunotherapy clinical trials as indicators of safe and effective cancer treatments in humans. Pet dog patients develop cancer spontaneously and the courses of disease and treatment responses are similar to those in humans. Canine clinical trial results are…